Areas of Research: Pluripotent stem cells, erythroid differentiation, red blood cells, epigenetics, DNA methylation, DNA replication, bioinformatics, allele-specific expression, gene therapy, hemoglobinopathies
Dr. Eric E. Bouhassira joined the Albert Einstein College of Medicine in 1990. He began studying human embryonic stem cells in 2001. He is director of the medical school's Center for Human Embryonic Stem Cell Research and professor of medicine and of cell biology. Dr. Bouhassira's research focuses on developing hematopoietic (blood forming) stem cells that can differentiate into red blood cells, T cells, platelets, and all other cell types that comprise blood. This work could potentially aid patients needing transfusions and also save lives by expanding the immunology diversity of hematopoietic stem cells available for transplant. Dr. Bouhassira is also interested in epigentic regulation in the erythoid and hematopoeitic lineag with a focus on DNA replication and DNA methylation. Dr. Bouhassira received his B.S., M.S., and Ph.D. degrees from the Université Pierre et Marie Curie in Paris, France. Dr. Bouhassira also holds the Ingeborg and Ira Rennert Chair in Stem Cell Biology and Regenerative Medicine.
Current Clinical Protocols
- In vitro red blood cell production
- Feasibility pilot study of therapies for sickle cell disease and Thalassemia
- Quartet sequencing and genome phasing
More Information About Dr. Eric Bouhassira
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
UPI features research by Drs. Mary E. Fabry and Eric E. Bouhassira which identifies a potential new treatment for thalassemia, a debilitating type of inherited anemia that affects millions of people worldwide.
Modern Healthcare interviews Drs. Eric Bouhassira and Jeffrey Pessin in a cover story on federal and state stem cell funding. The cover, entitled, Dishing it Out, appears in the March 16th edition.
More media coverage